Neurocrine Biosciences Inc (NBIX)
125.00
+1.71
(+1.39%)
USD |
NASDAQ |
Nov 21, 16:00
123.15
-1.85
(-1.48%)
After-Hours: 20:00
Neurocrine Biosciences Profit Margin (Quarterly): 20.86% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 20.86% |
| June 30, 2024 | 11.01% |
| March 31, 2024 | 8.42% |
| December 31, 2023 | 28.67% |
| September 30, 2023 | 16.66% |
| June 30, 2023 | 21.10% |
| March 31, 2023 | -18.22% |
| December 31, 2022 | 21.60% |
| September 30, 2022 | 17.66% |
| June 30, 2022 | -4.47% |
| March 31, 2022 | 4.48% |
| December 31, 2021 | -2.34% |
| September 30, 2021 | 7.60% |
| June 30, 2021 | 14.64% |
| March 31, 2021 | 13.57% |
| December 31, 2020 | |
| September 30, 2020 | -22.28% |
| June 30, 2020 | 26.32% |
| March 31, 2020 | 15.77% |
| December 31, 2019 | 13.93% |
| September 30, 2019 | 24.22% |
| June 30, 2019 | 27.96% |
| March 31, 2019 | -73.77% |
| December 31, 2018 | 13.74% |
| September 30, 2018 | 33.45% |
| Date | Value |
|---|---|
| June 30, 2018 | -6.10% |
| March 31, 2018 | -58.83% |
| December 31, 2017 | 7.29% |
| September 30, 2017 | -18.31% |
| June 30, 2017 | -946.9% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | -128.4% |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -6.03% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -1.46K% |
| September 30, 2013 | -1.53K% |
| June 30, 2013 | -1.68K% |
| March 31, 2013 | -1.65K% |
| December 31, 2012 | 43.24% |
| September 30, 2012 | -32.90% |
| June 30, 2012 | -4.74% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-22.28%
Minimum
Sep 2020
28.67%
Maximum
Dec 2023
10.26%
Average
13.93%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Repligen Corp | -0.42% |
| West Pharmaceutical Services Inc | 18.21% |
| Bruker Corp | 4.73% |
| The Cooper Companies Inc | 10.44% |
| Integra Lifesciences Holdings Corp | -2.81% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.28% |
| Return on Assets | 11.76% |
| Return on Invested Capital | 15.50% |
| Gross Profit Margin (Quarterly) | 98.71% |
| Operating Margin (Quarterly) | 29.71% |
| Return on Net Operating Assets | 46.54% |